News

FDA approves new diabetes treatment

In late September 2019, the U.S. Food and Drug Administration (FDA) approved a new oral treatment for type 2 diabetes. Novo Nordisk’s Rybelsus (semaglutide)…

FDA announces Project Orbis

The U.S. Food and Drug Administration (FDA) has announced Project Orbis, a new initiative from the FDA Oncology Center of Excellence (OCE), which will…

FDA announces Project Orbis

The U.S. Food and Drug Administration (FDA) has announced Project Orbis, a new initiative from the FDA Oncology Center of Excellence (OCE),…

Poll

Julie NyhusGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.